Gedeon Richter Spends Most On Biosimilar R&D

Multiple Candidates In Clinical Phase Including Denosumab

 
• By Dean Rudge
  
Clinical_Trial_Globe
Biosimilar Prolia/Xgeva and Actemra/RoActemra candidates are entering the clinical phase • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products